Hepatitis B reactivation with pembrolizumab, atezolizumab, and nivolumab: A pharmacovigilance study and literature review.

Muhsen, I; Burns, E; Umoru, G; Arain, A; Xu, JQ; Abdelrahim, M

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):